SQZ Biotechnologies Company
SQZ Biotech's CellSqueeze (invented at MIT) enables delivery of molecules into cells by a gentle squeezing. That's right, we squeeze cells.
- Stage $500K in TTM Revenue
- Industry Biotechnology
- Location Cambridge, MA, US
- Currency USD
- Founded March 2013
- Employees 9
- Website sqzbiotech.com
Company Summary
SQZ Biotech’s CellSqueeze enables the delivery of molecules into cells by a gentle squeezing. It was invented at MIT in the lab of Prof. Bob Langer. It's shown 10-100x improvement relative to competing technologies for major unmet needs: primary cells and non-nucleid acid molecules (proteins...). We own the exclusive license from MIT. We started in the research market but plan to pursue higher impact applications (therapeutics...) in the future.
Team
-
MIT M.S. '09. 6 years of experience at P&G and Novartis. At P&G, he led the development and launch of a +$5m NPV product in Latin America. The product was then successfully launched in Asia and Europe. At Novartis, he led projects that resulted in $10m savings and he was the Value Chain Manager for the Meningitis' vaccines franchise ($400m annual sales) before joining SQZ Biotech.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.